Innovation and Optimization of Radiation or Drug Therapy for Gynecological Cancers
A Special Issue of Cancers (ISSN 2072-6694) belonging to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 December 2026 | Viewed by 594
Editors
Interests: cervical cancer; radiation therapy; immunotherapy; comprehensive treatment; cost-effectiveness
Special Issue Information
Dear Colleagues,
Gynecological tumors are one of the most common and difficult-to-treat types of cancer. Radiation therapy combined with other treatments plays a significant role in the treatment of gynecological tumors. As incidence and recurrence rates increase, more and more oncologists and clinical trial pioneers are paying attention to innovative treatment methods for gynecological tumors. However, with the emergence of numerous treatment methods, we must make comprehensive judgments on the optimal choice among these innovative treatment options. Therefore, new research strategies and evaluation methods are needed to better formulate future treatment plans for gynecological tumors.
The focus of this Special Issue lies in exploring the following research aspects of comprehensive treatment for gynecological tumors: (a) radiation therapy; (b) immunotherapy; (c) molecular targeted drugs; (d) clinical trials or real-world research analysis; (e) meta-analysis or cost-effectiveness analysis.
Prof. Dr. Hong Zhu
Dr. Yangying Zhou
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cervical cancer
- endometrial cancer
- ovarian cancer
- radiation therapy
- immunotherapy
- targeted therapy
- comprehensive treatment
- cost-effectiveness
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
